feed,title,long_url,short_url
Benzinga,"Myelodysplastic Syndrome Market to Climb Swiftly at a 13.2% CAGR During the Study Period [2018-2030], Evaluates DelveInsight",https://benzinga.com/pressreleases/22/03/n26041556/myelodysplastic-syndrome-market-to-climb-swiftly-at-a-13-2-cagr-during-the-study-period-2018-2030-,
